Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-23-027800

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 11, 2023 32.63M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $53.4K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $37.04K
Current Liabilities Q2 2023 · Jun 30, 2023 $3.78M
Current Liabilities Q2 2023 · Dec 31, 2022 $3.65M
Total Liabilities Q2 2023 · Jun 30, 2023 $3.92M
Total Liabilities Q2 2023 · Dec 31, 2022 $3.8M
Current Assets Q2 2023 · Jun 30, 2023 $618.37K
Current Assets Q2 2023 · Dec 31, 2022 $517.76K
Total Assets Q2 2023 · Jun 30, 2023 $905.44K
Total Assets Q2 2023 · Dec 31, 2022 $860.18K
Shares Diluted Q2 2023 · Jun 30, 2022 31.46M sh
Shares Diluted Q2 2023 · Jun 30, 2022 31.44M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$106.92K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$2.6M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$2.59M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$2.4M
Eps Diluted Q2 2023 · Jun 30, 2022 $0.00
Eps Diluted Q2 2023 · Jun 30, 2022 $0.01
Eps Basic Q2 2023 · Jun 30, 2022 $0.00
Eps Basic restated Q2 2023 · Jun 30, 2022 $0.01
Sga Expense Q2 2023 · Jun 30, 2022 $359.76K
Sga Expense Q2 2023 · Jun 30, 2022 $678.44K
Net Income Q2 2023 · Jun 30, 2022 −$99.01K
Net Income Q2 2023 · Jun 30, 2022 −$173.56K
Operating Income Q2 2023 · Jun 30, 2022 −$74.37K
Operating Income Q2 2023 · Jun 30, 2022 −$127.27K
Gross Profit Q2 2023 · Jun 30, 2022 $300.04K
Gross Profit Q2 2023 · Jun 30, 2022 $580.46K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $27.89K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $61.29K
Revenue Q2 2023 · Jun 30, 2022 $327.92K
Revenue Q2 2023 · Jun 30, 2022 $641.76K